Purchase Order W81K0022P0141
- Not listed
- The Defense Health Agency awarded Cepheid Inc. a purchase order valued at approximately $208K for GeneXpert maintenance services under a new buy for Fiscal Year 2023. The contract, which carries a firm fixed-price structure with no set-aside designation, runs through July 31, 2028, and will be performed at Fort Moore, Georgia. This maintenance agreement supports Cepheid's GeneXpert diagnostic systems, molecular diagnostic platforms that the company manufactures for detection of infectious...
- The Defense Health Agency awarded a $175.8K firm fixed-price purchase order to Cepheid for GeneXpert System maintenance services at Quantico, VA, with an ultimate completion date of October 7, 2029. This contract represents a continuation of Cepheid's longstanding role as a primary supplier of molecular diagnostic solutions to the Department of Defense and broader federal healthcare ecosystem. Cepheid, a Sunnyvale, California-based manufacturer specializing in advanced diagnostic systems and...
- The Defense Health Agency awarded a $225.55K firm fixed-price purchase order to Cepheid Inc. for onsite preventive maintenance, software and hardware updates, and repair and parts replacement services for government-owned Cepheid GeneXpert molecular analyzers. The contract, effective through September 19, 2030, supports diagnostic equipment located in Columbia, South Carolina. This award carries no set-aside designation and reflects the Defense Health Agency's continued reliance on molecular...
- The Defense Health Agency awarded a firm fixed-price purchase order to Cepheid Inc. for annual preventive maintenance services, with a ceiling value of $215.9K and a completion date of June 30, 2027. The contract, awarded July 1, 2022, will be performed in San Antonio, Texas, and represents a continuation of Cepheid's support for federal diagnostic equipment operations. This award carries no set-aside designation and reflects the standard procurement approach for maintenance services across...
- The Defense Health Agency has awarded a $338,325 firm fixed-price purchase order to Cepheid Inc. for annual maintenance and calibration services on GeneXpert COVID-19 testing systems. The contract, awarded on October 1, 2025, will run through September 30, 2030, and be performed at Fort Leonard Wood, Missouri. This award supports the Defense Health Agency's operational needs for molecular diagnostic equipment maintenance, ensuring continued reliability and accuracy of COVID-19 detection...
- The U.S. Defense Health Agency (DHA) awarded a $88,596.00 firm fixed-price purchase order to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions, for annual preventative maintenance check-ups on equipment parts. This award is not associated with a larger contract vehicle and does not have a set-aside designation. Cepheid is a prime contractor that specializes in advanced diagnostic systems and test kits for infectious diseases, genetic conditions, and clinical testing....
- The Defense Health Agency awarded a $153,675 firm fixed-price purchase order to Cepheid Inc. on July 29, 2025, for maintenance services on government-owned Cepheid GeneXpert Molecular Analyzers at Fort Drum, New York. This sole-source procurement was conducted under Federal Acquisition Regulation 13.106-1(b)(1)(i), as Cepheid is the sole manufacturer of the GeneXpert systems and the only authorized provider of the required maintenance services. The contract does not utilize a set-aside...
- The Defense Health Agency has awarded a firm-fixed-price purchase order to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for a GeneXpert IV Service Agreement plus four option years. The contract, valued at $36,197.21, will provide GeneXpert diagnostic equipment, reagents, consumables, and maintenance services to support clinical testing programs for the agency. Cepheid is the prime contractor and original equipment manufacturer, and the contract does not have a...
- This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for $13,000.50 to provide maintenance service for GeneXpert diagnostic equipment. The contract has an ultimate completion date of April 17, 2025. Cepheid is a leading provider of diagnostic equipment, reagents, and support services to federal agencies, including the Department of Veterans Affairs (VA) and Department of Health and Human...
- The Defense Health Agency awarded a $265,880 firm fixed-price purchase order to Cepheid Inc. for a full-service maintenance agreement covering five GeneXpert diagnostic systems at Carl R. Darnall Army Medical Center's Biomedical Engineering Branch located at Fort Cavazos, Texas. The contract includes a base year of performance through fiscal year 2026 plus three optional years, with an ultimate completion date of September 30, 2029. The award carries no set-aside designation, reflecting...
The Defense Health Agency awarded a $127,000 firm fixed-price purchase order to Cepheid Inc. for annual preventive maintenance services on Cepheid GeneXpert molecular diagnostic systems at Fort Irwin, California. The contract, awarded on June 2, 2022, extends through May 31, 2027, with no set-aside designation. Cepheid, a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, specializes in providing diagnostic equipment and comprehensive maintenance services to federal healthcare systems, including the Department of Veterans Affairs and Defense Logistics Agency. This maintenance contract supports Cepheid's GeneXpert diagnostic platform, which the Defense Health Agency employs for infectious disease testing and clinical diagnostics across its military medical facilities. The award reflects Cepheid's established position as a primary provider of molecular diagnostic technologies to federal defense and healthcare agencies. The company maintains two significant Veterans Affairs IDV contracts valued at over $35 million collectively, underscoring its critical role in supplying diagnostic testing systems and related services to the federal healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Funding Only Action | $25.4k | 8/26/25 | |
| P00003 | Exercise an Option | $0 | 2/27/25 | |
| P00002 | Exercise an Option | $25.4k | 5/15/24 | |
| P00001 | Exercise an Option | $25.4k | 5/30/23 | |
| Not listed | Not listed | $25.4k | 6/2/22 |